Publication | Closed Access

Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer—a multicentre, open, controlled, prospectively randomised trial

Adjuvant Endocrine TreatmentMedroxyprogesterone AcetateEndocrine OncologyMedicineGynecologyEndocrinologyOncologyRadiation OncologyGynecology OncologyEndocrine-related Cancer